|1.||Boldt, Joachim: 3 articles (08/2010 - 02/2006)|
|2.||Van Eenoo, P: 1 article (06/2014)|
|3.||Esposito, S: 1 article (06/2014)|
|4.||Deventer, K: 1 article (06/2014)|
|5.||Roels, K: 1 article (06/2014)|
|6.||Herregods, L: 1 article (06/2014)|
|7.||Verstraete, A: 1 article (06/2014)|
|8.||Giron, A J: 1 article (06/2014)|
|9.||Kuntsche, Judith: 1 article (06/2013)|
|10.||Leimert, Anja: 1 article (06/2013)|
01/01/1980 - "Skeletal muscle microcirculation and oxygenation in experimental intestinal shock: A study on the efficacy of different plasma substitutes."
12/01/1951 - "Present status of plasma volume expanders in the treatment of shock; clinical laboratory studies."
03/01/2007 - "Do plasma substitutes have additional properties beyond correcting volume deficits?: Shock 25:2103-116, 2006."
01/01/1983 - "Plasma and plasma substitutes are used in the treatment of various conditions such as haemorrhage and shock. "
01/01/1981 - "The present experiments compare the relative effectiveness of several plasma substitutes to reverse a standardized intestinal ischemic shock in dogs and rats. "
01/01/1986 - "[Transport of substances in the nephron of the denervated kidney after hemorrhage and administration of plasma substitutes (experimental study)]."
10/01/1991 - "An in vitro model of surgical bleeding was developed to simulate continuous blood loss and replacement therapy with plasma substitutes and red cell concentrates. "
08/01/1952 - "The retention of certain plasma volume expanders within the circulation of human subjects following a 1,000 cubic centimeter hemorrhage; a preliminary report."
06/01/1984 - "[Combined use of plasma substitutes and mannitol for the treatment of acute experimental hemorrhage]."
11/01/1969 - "[Solvents for plasma substitutes, with special reference to the therapy of experimental massive hemorrhage]."
04/26/1968 - "[Animal experimental studies on the effect of colloidal plasma substitutes in canine hemorrhagic shock]."
01/01/1969 - "Animal experiments on the effect of colloidal plasma substitutes in hemorrhagic shock in the dog."
06/01/1968 - "[Management of hemorrhagic shock using plasma substitutes. "
05/01/1966 - "[Peripheral blood circulation in hemorrhagic shock and effects of various plasma substitutes]."
05/01/1983 - "[The effect of blood transfusion and plasma substitutes on microcirculation during the late period of hemorrhagic shock]."
|5.||Surgical Blood Loss
02/01/1995 - "Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes."
08/01/1995 - "The purpose of this study was to assess the change of platelet and fibrinogen concentrations and the change of activities of prothrombin and factors V and VII when major surgical blood loss was replaced with plasma-poor red cell concentrates (RCCs) and colloid plasma substitutes. "
|8.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|9.||Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
|10.||Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
|1.||Cardiopulmonary Bypass (Heart-Lung Bypass)
|3.||Blood Transfusion (Blood Transfusions)